Clear Light Ventures

Clear Light Ventures is a private research and investment firm dedicated to investigating the impact of environmental toxins on human health, with a primary focus on mercury toxicity. Founded by David Lewis, the organization funds and conducts scientific research to uncover the biochemical mechanisms through which mercury exposure may contribute to neurological conditions such as autism. The firm operates at the intersection of environmental science and toxicology, providing funding and expertise to advance the understanding of heavy metal impacts. Clear Light Ventures emphasizes the importance of identifying environmental triggers to improve public health outcomes and advocates for increased transparency in medical and environmental safety. While not a traditional pharmaceutical developer, its work supports academic collaborations and public awareness initiatives aimed at mitigating environmental health risks.